The clinical significance of pancreatic steatosis

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 3, 2011, Pages 169-177

  Smits, Mark M ^a   Van Geenen, Erwin J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE; GEMCITABINE; STEROID;

ABDOMINAL RADIOGRAPHY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE PANCREATITIS; ADJUVANT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL DISORDER; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECHOGRAPHY; ENZYME BLOOD LEVEL; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; LIPID STORAGE; MALNUTRITION; METABOLIC SYNDROME X; NOMENCLATURE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PANCREAS CANCER; PANCREAS DISEASE; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS FISTULA; PANCREAS ISLET CELL FUNCTION; PANCREAS TRANSPLANTATION; PANCREATIC STEATOSIS; PANCREATOGRAPHY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STEATOSIS;

DIABETES MELLITUS, TYPE 2; HUMANS; LIPID METABOLISM DISORDERS; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; PANCREATITIS; RISK FACTORS;

EID: 79952443077     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2011.4     Document Type: Review

References (127)

1. Berghöfer, A. et al. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 8, 200 (2008).
2. Flegal, K. M., Carroll, M. D., Ogden, C L. & Curtin, L. R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303, 235-241 (2010).
3. Wilson, P. W., D'Agostino, R. B., Sullivan, L., Parise, H. & Kannel, W. B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 162, 1867-1872 (2002).
4. Ogden, C L., Yanovski, S. Z., Carroll, M. D. & Flegal, K. M. The epidemiology of obesity Gastroenterology 132, 2087-2102 (2007). (Pubitemid 46693751)
5. Calle, E. E., Rodriguez, C., walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of, U. S. adults. N. Engl. J. Med. 348, 1625-1638 (2003). (Pubitemid 36459468)
6. Van Herpen, N. A. & Schrauwen-Hinderling, V B. Lipid accumulation in non-adipose tissue and ipotoxicity. Physiol. Behav. 94, 231-241 (2008). (Pubitemid 351615422)
7. Van Geenen, E. J. et al. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 39, 1185-1190 (2010).
8. Ogilvie, R. The island of langerhans in 19 cases of obesity. J. Pathol. 37, 473-481 (1933).
9. Olsen, T S. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol. Microbiol. Scand. A 86a, 367-373 (1978) (Pubitemid 9031936)
10. Stamm, B. H. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease. Hum. Pathol. 15, 677-683 (1984). (Pubitemid 15161459)
11. Al-Haddad, M. et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 38, 672-675 (2009).
12. Lee, Y et al. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int. J. Obes. (Lond.) 34, 396-400 (2010).
13. Lingvay, I. et al. Noninvasive quantification of pancreatic fat in humans. J. Clin. Endocrinol. Metab. 94, 4070-4076 (2009).
14. Lozano, M. et al. Lipomatosis of the pancreas: an unusual cause of massive steatorrhea. Pancreas 3, 580-582 (1988). (Pubitemid 19053251)
15. Schwenzer, N. F et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest. Radiol. 43, 330-337 (2008). (Pubitemid 351572210)
16. Walters, M. N., Leak, P J., Joske, R. A., Stanley, N. F & Perret, D. H. Murine infection with reovirus 3. Pathology of infection with types 1 and 2. Br. J. Exp. Pathol. 46, 200-212 (1965).
17. Lin, W. C., Chen, J. H., Lin, C H. & Shen, W. C Rapidly progressive pancreatic lipomatosis in a young adult patient with transfusion-dependent myelodysplastic syndrome. J. Formos. Med. Assoc 106, 676-679 (2007). (Pubitemid 47377261)
18. Feigelson, J. et al. Imaging changes in the pancreas in cystic fibrosis: a retrospective evaluation of 55 cases seen over a period of 9 years. J. Pediatr. Gastroenterol. Nutr. 30, 145-151 (2000). (Pubitemid 30366190)
19. Makay, O. et al. Fat replacement of the malignant pancreatic tissue after neoadjuvant therapy. Int. J. Clin. Oncol. 15, 88-92 (2010).
20. López, J. M. et al. Effects of prolonged ethanol intake and malnutrition on rat pancreas. Gut 38, 285-292 (1996). (Pubitemid 26046827)
21. Wilson, J. S., Somer, J. B. & Pirola, R. C Chronic ethanol feeding causes accumulation of serum cholesterol in rat pancreas. Exp. Mol. Pathol. 41, 289-297 (1984). (Pubitemid 15197459)
22. Wilson, J. S. et al. Alcohol causes a fatty pancreas. A rat model of ethanol-induced pancreatic steatosis. Alcohol Clin. Exp. Res. 6, 117-121 (1982). (Pubitemid 12187126)
23. Altinel, D. et al. Lipomatous pseudohypertrophy of the pancreas: a clinicopathologically distinct entity Pancreas 39, 392-397 (2010).
24. Larsen, M. O. et al. Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Gottingen minipigs. Am. J. Physiol. Endocrinol. Metab. 288, E412-E421 (2005). (Pubitemid 40110651)
25. Mathur, A. et al. Nonalcoholic fatty pancreas disease. HPB (Oxford) 9, 312-318 (2007). (Pubitemid 47271323)
26. Patel, S., Bellon, E. M., Haaga, J. & Park, C H. Fat replacement of the exocrine pancreas. AJR Am. J. Roentgenol. 135, 843-845 (1980). (Pubitemid 10004624)
27. Winston, C B., Mitchell, D. G., Outwater, E. K. & Ehrlich, S. M. Pancreatic signal intensity on T1-weighted fat saturation MR images: clinical correlation. J. Magn. Reson. Imaging 5, 267-271 (1995).
28. th edn (Saunders Elsevier, Philadelphia, 2009).
29. Tushuizen, M. E. et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 30, 2916-2921 (2007). (Pubitemid 350083144)
30. Mathur, A. et al. Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J. Am. Coll. Surg. 208, 989-994 (2009).
31. Walters, M. N. Adipose atrophy of the exocrine pancreas. J. Pathol. Bacteriol. 92, 547-557 (1966).
32. Pinnick, K. E. et al. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 16, 522-530 (2008). (Pubitemid 351328001)
33. Dreiling, D. A., Elsbach, P, Schaffner, F & Schwartz, I. L. The effect of restriction of protein and total calories on pancreatic function in obese patients. Gastroenterology 42, 686-690 (1962).
34. Jia, D. M., Fukumitsu, K. I., Tabaru, A., Akiyama, T & Otsuki, M. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1332-R1340 (2001).
35. Raeder, H. et al. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes 56, 444-449 (2007).
36. Kuroda, N., Okada, M., Toi, M., Hiroi, M. & Enzan, H. Lipomatous pseudohypertrophy of the pancreas: further evidence of advanced hepatic lesion as the pathogenesis. Pathol. Int 53, 98-101 (2003). (Pubitemid 36332373)
37. Yang, D. M., Kim, H. C., Ryu, J. K., Joo, K. R. & Ahn, K. J. Sonographic appearance of focal fatty infiltration of the pancreas. J. Clin. Ultrasound 38, 45-47 (2010).
38. Mathur, A. et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann. Surg. 246, 1058-1064 (2007). (Pubitemid 350179200)
39. Saisho, Y et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin. Anat 20, 933-942 (2007). (Pubitemid 350074312)
40. Matsumoto, S. et al. Uneven fatty replacement of the pancreas: evaluation with CT Radiology 194, 453-458 (1995).
41. Cnop, M., Hannaert, J. C., Hoorens, A., Eizirik, D. L. & Pipeleers, D. G. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50, 1771-1777 (2001). (Pubitemid 33641595)
42. Schneider, K., Harms, K. & Fendel, H. The increased echogenicity of the pancreas in infants and children: the white pancreas. Eur. J. Pediatr. 146, 508-511 (1987). (Pubitemid 18053156)
43. Shawker, T H., Linzer, M. & Hubbard, V S. Chronic pancreatitis: the diagnostic significance of pancreatic size and echo amplitude. J. Ultrasound Med. 3, 267-272 (1984). (Pubitemid 14056255)
44. Lee, J. S. et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J. Gastroenterol. 15, 1869-1875 (2009).
45. Worthen, N. J. & Beabeau, D. Normal pancreatic echogenicity: relation to age and body fat. AJR Am. J. Roentgenol. 139, 1095-1098 (1982). (Pubitemid 13201957)
46. Katz, D. S. et al. Using CT to reveal fat-containing abnormalities of the pancreas. AJR Am. J. Roentgenol. 172, 393-396 (1999). (Pubitemid 29082652)
47. Kim, H. J. et al. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. AJR Am. J. Roentgenol. 188, 429-432 (2007). (Pubitemid 46167745)
48. Kovanlikaya, A. et al. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr. Radiol. 35, 601-607 (2005). (Pubitemid 40724032)
49. Lacaille, F., Mani, T M., Brunelle, F., Lallemand, D. & Schmitz, J. Magnetic resonance maging for diagnosis of Shwachman's syndrome. J. Pediatr. Gastroenterol. Nutr. 23, 599-603 (1996). (Pubitemid 27009111)
50. Isserow, J. A., Siegelman, E. S. & Mammone, J. Focal fatty infiltration of the pancreas: MR characterization with chemical shift imaging. AJR Am. J. Roentgenol. 173, 1263-1265 (1999). (Pubitemid 29494003)
51. Hu, H. H., Kim, H. W., Nayak, K. S. & Goran, M. I. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 18, 841-847 (2010).
52. Kim, K. H. et al. Endoscopic retrograde pancreatographic findings of pancreatic ipomatosis. J. Korean Med. Sci. 14, 578-581 (1999).
53. Fraulob, J. C., Ogg-Diamantino, R., Fernandes-Santos, C., Aguila, M. B. & Mandarim-de-Lacerda, C A. A mouse model of metabolic syndrome: insulin resistance, fatty iver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J. Clin. Biochem. Nutr. 46, 212-223 (2010).
54. Gaujoux, S. et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery 148, 15-23 (2010).
55. Heni, M. et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab. Res. Rev. 26, 200-205 (2010).
56. Rosso, E. et al. The role of "fatty pancreas" and of BMI in the occurrence of pancreatic fistula after pancreaticoduodenectomy J. Gastrointest. Surg. 13, 1845-1851 (2009).
57. Zyromski, N. J. et al. Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology. Pancreatology 9, 410-419 (2009).
58. Sodhi, K. S., Thapa, B. R., Khandelwal, S. & Suri, S. Pancreatic lipomatosis in an infant with cystic fibrosis. Pediatr. Radiol. 35, 1157-1158 (2005). (Pubitemid 41554595)
59. Soyer, P et al. Cystic fibrosis in adolescents and adults: fatty replacement of the pancreas\CT evaluation and functional correlation. Radiology 210, 611-615 (1999). (Pubitemid 29124017)
60. Robertson, M. B., Choe, K. A. & Joseph, P. M. Review of the abdominal manifestations of cystic fibrosis in the adult patient. Radiographics 26, 679-690 (2006). (Pubitemid 43824969)
61. Carucci, L. R. & Jacobs, J. E. Focal fatty sparing of the pancreatic head in cystic fibrosis: CT findings. Abdom. Imaging 28, 853-855 (2003). (Pubitemid 37351758)
62. King, L. J. et al. Hepatobiliary and pancreatic manifestations of cystic fibrosis: MR imaging appearances. Radiographics 20, 767-777 (2000).
63. Lugo-Olivieri, C H., Soyer, P A. & Fishman, E. K. Cystic fibrosis: spectrum of thoracic and abdominal CT findings in the adult patient. Clin. Imaging 22, 346-354 (1998). (Pubitemid 28445812)
64. Tsushima, Y., Matsumoto, M., Inaba, S., watanabe, M. & Ohno, Y A Japanese adult case of cystic fibrosis causing bone demineralization. Radiat Med. 10, 157-162 (1992).
65. Tham, R. T. et al. Cystic fibrosis: MR imaging of the pancreas. Radiology 179, 183-186 (1991).
66. Murayama, S. et al. MR imaging of pancreas in cystic fibrosis. Pediatr. Radiol. 20, 536-539 (1990). (Pubitemid 20234785)
67. Fiel, S. B. et al. Magnetic resonance imaging in young adults with cystic fibrosis. Chest 91, 181-184 (1987). (Pubitemid 17010926)
68. Daneman, A., Gaskin, K., Martin, D. J. & Cutz, E. Pancreatic changes in cystic fibrosis: CT and sonographic appearances. AJR Am. J. Roentgenol. 141, 653-655 (1983). (Pubitemid 13004546)
69. Jones, J. S. Adult cystic fibrosis (mucoviscidosis). Fatty replacement of the pancreas in a woman aged 47 years. Br. J. Dis. Chest 64, 25-36 (1970).
70. Ruggiero, A. et al. MRI findings in Shwachman diamond syndrome. Pediatr. Blood Cancer 50, 352-354 (2008).
71. Belkind-Gerson, J., Ontiveros-Nevares, P, Ocampo-Roosens, V & Sandoval-Juaréz, D. Shwachman-Diamond syndrome in a Mexican family. Arch. Med. Res. 32, 318-323 (2001). (Pubitemid 32618659)
72. Lee, J. H. et al. A case of Shwachman-Diamond syndrome confirmed with genetic analysis in a Korean child. J. Korean Med. Sci. 23, 142-145 (2008).
73. Cubuk, M., Arslan, G., Ceken, K., Ozkaynak, C & Lüyleci, E. Schwachman-Diamond syndrome. A case report. Acta Radiol. 41, 627-628 (2000).
74. Kurdziel, J. C & Dondelinger, R. Fatty infiltration of the pancreas in Shwachman's syndrome: computed tomography demonstration. Eur. J. Radiol. 4, 202-204 (1984). (Pubitemid 14030357)
75. Daentl, D. L., Frias, J. L., Gilbert, E. F & Opitz, J. M. The Johanson-Blizzard syndrome: case report and autopsy findings. Am. J. Med. Genet 3, 129-135 (1979). (Pubitemid 10132346)
76. Volk, B. W. & wellman, K. F The Diabetic Pancreas 317-324 (Plenum Press, New York, 1977).
77. Papakonstantinou, O. et al. The pancreas in beta-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbances. Eur. Radiol. 17, 1535-1543 (2007). (Pubitemid 46767602)
78. Midiri, M. et al. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major. AJR Am. J. Roentgenol. 173, 187-192 (1999). (Pubitemid 29291114)
79. Park, C M., Han, J. K., Kim, T K. & Choi, B. I. Fat replacement with absence of acinar and ductal structure in the pancreatic body and tail. J. Comput Assist Tomogr. 24, 893-895 (2000). (Pubitemid 32201816)
80. Fernandes-Santos, C., Evangelista, C R., de Souza, M. L., Barbosa, A. M. & Mandarim-de-Lacerda, C A. Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas 38, e80-e86 (2009).
81. Watanabe, S., Abe, K., Anbo, Y & Katoh, H. Changes in the mouse exocrine pancreas after pancreatic duct ligation: a qualitative and quantitative histological study. Arch. Histol. Cytol. 58, 365-374 (1995).
82. Kimura, W. Histological study on pathogenesis of sites of isolated islets of Langerhans and their course to the terminal state. Am. J. Gastroenterol. 84, 517-522 (1989). (Pubitemid 19143072)
83. Sasaki, M., Nakanuma, Y & Ando, H. Lipomatous pseudohypertrophy of the pancreas in a patient with cirrhosis due to chronic hepatitis B. Pathol. Int 48, 566-568 (1998).
84. Diamond, I. & Vallbona, C Kwashiorkor in a North American white male. Pediatrics 25, 248-257 (1960).
85. Chehter, E. Z., Longo, M. A., Laudanna, A. A. & Duarte, M. I. Involvement of the pancreas in AIDS: a prospective study of 109 post-mortems. AIDS 14, 1879-1886 (2000).
86. Olufadi, R. & Byrne, C D. Clinical and laboratory diagnosis of the metabolic syndrome. J. Clin. Pathol. 61, 697-706 (2008). (Pubitemid 351859961)
87. Musso, G. et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 31, 562-568 (2008).
88. Kahn, S. E., Hull, R. L & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846 (2006). (Pubitemid 46024990)
89. Van Raalte, D. H., van der Zijl, N. J. & Diamant, M. Pancreatic steatosis in humans: cause or marker of lipotoxicity? Curr. Opin. Clin. Nutr. Metab. Care 13, 478-485 (2010).
90. Lee, Y et al. β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc. Natl Acad. Sci. USA 91, 10878-10882 (1994).
91. Van der Zijl, N. J. et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on ß-cell function in individuals with impaired glucose metabolism. J. Clin. Endocrinol. Metab. doi:10.1210/jc.2010- 1722.
92. Szendroedi, J. & Roden, M. Ectopic lipids and organ function. Curr. Opin. Lipidol. 20, 50-56 (2009).
93. DiMagno, E. P, Go, V L. & Summerskill, W. H. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N. Engl. J. Med. 288, 813-815 (1973).
94. Savvina, T V A histotopographic study of the pancreas in lipomatosis [Russian]. Arkh. Patol. 38. 68-73 (1976).
95. Dupont, C et al. Pancreatic lipomatosis and duodenal stenosis or atresia in children. J. Pediatr. 115, 603-605 (1989). (Pubitemid 19248842)
96. So, C B., Cooperberg, P L., Gibney, R. G. & Bogoch, A. Sonographic findings in pancreatic lipomatosis. AJR Am. J. Roentgenol. 149, 67-68 (1987). (Pubitemid 17094999)
97. Aubert, A. et al. Diffuse primary fat replacement of the pancreas: an unusual cause of steatorrhea [French]. Gastroenterol. Clin. Biol. 31, 303-306 (2007). (Pubitemid 46555717)
98. Martínez, J. et al. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology 4, 42-48 (2004). (Pubitemid 38453121)
99. Martínez, J. et al. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 6, 206-209 (2006). (Pubitemid 44114487)
100. Zyromski, N. J. et al. A murine model of obesity mplicates the adipokine milieu in the pathogenesis of severe acute pancreatitis. Am. J. Physiol. Gastrointest Liver Physiol. 295, G552-G558 (2008).
101. Lankisch, P G. & Schirren, C A. Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis. Pancreas 5, 626-629 (1990). (Pubitemid 20260429)
102. Suazo-Baráhona, J. et al. Obesity: a risk factor for severe acute biliary and alcoholic pancreatitis. Am. J. Gastroenterol. 93, 1324-1328 (1998). (Pubitemid 29076935)
103. Blomgren, K. B., Sundström, A., Steineck, G. & wiholm, B. E. Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Diabetes Care 25, 298-302 (2002). (Pubitemid 41079625)
104. Funnell, I. C., Bornman, P C., weakley, S. P, Terblanche, J. & Marks, I. N. Obesity: an important prognostic factor in acute pancreatitis. Br. J. Surg. 80, 484-486 (1993). (Pubitemid 23116090)
105. Frossard, J. L., Lescuyer, P & Pastor, C M. Experimental evidence of obesity as a risk factor for severe acute pancreatitis. World J. Gastroenterol. 15, 5260-5265 (2009).
106. Ronti, T., Lupattelli, G. & Mannarino, E. The endocrine function of adipose tissue: an update. Clin. Endocrinol. (Oxf.) 64, 355-365 (2006).
107. Shoelson, S. E., Herrero, L. & Naaz, A. Obesity inflammation, and insulin resistance. Gastroenterology 132, 2169-2180 (2007).
108. McCullough, A. J. Pathophysiology of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 40 (Suppl. 1), S17-S29 (2006). (Pubitemid 44309539)
109. Norman, J. G. New approaches to acute pancreatitis: role of inflammatory mediators. Digestion 60 (Suppl. 1), 57-60 (1999). (Pubitemid 29110477)
110. Pitt, H. A. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 9, 92-97 (2007). (Pubitemid 46672381)
111. Vaino, H. & Bianchini, F IARC Handbook of Cancer Prevention: Weight Control and Physical Activity Vol. 6 (IARC Press, Lyon, 2002).
112. Joint wHO/FAO expert consultation. Diet, nutrition and the prevention of chronic diseases. [online], http://www.who.int/dietphysicalactivity/ publications/trs916/en (2003).
113. Larsson, S. C., Orsini, N. & wolk, A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J. Cancer 120, 1993-1998 (2007). (Pubitemid 46418379)
114. Gumbs, A. A., Bessler, M., Milone, L., Schrope, B. & Chabot, J. Contribution of obesity to pancreatic carcinogenesis. Surg. Obes. Relat Dis. 4, 186-193 (2008).
115. Zyromski, N. J. et al. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery 146, 258-263 (2009).
116. Toyama, N. et al. Pancreas head carcinoma with total fat replacement of the dorsal exocrine pancreas. J. Gastroenterol. 39, 76-80 (2004). (Pubitemid 38208248)
117. Eriguchi, N. et al. Insulinoma occurring in association with fatty replacement of unknown etiology in the pancreas: report of a case. Surg. Today 30, 937-941 (2000).
118. Shimizu, M., Hirokawa, M., Matsumoto, T., Iwamoto, S. & Manabe, T Fatty replacement of the pancreatic body and tail associated with leiomyosarcoma of the pancreatic head. Pathol. Int 47, 633-636 (1997). (Pubitemid 27414958)
119. Cohen, D. J. & Fagelman, D. Pancreas islet cel carcinoma with complete fatty replacement: CT characteristics. J. Comput Assist Tomogr. 10, 1050-1051 (1986). (Pubitemid 17200115)
120. Lee, S. E. et al. Measurement of pancreatic fat by magnetic resonance imaging: predicting the occurrence of pancreatic fistula after pancreatoduodenectomy. Ann. Surg. 251, 932-936 (2010).
121. Hanish, S. I. et al. Obesity predicts increased overall complications following pancreas transplantation. Transplant Proc 37, 3564-3566 (2005). (Pubitemid 41659954)
122. Humar, A. et al. The impact of donor obesity on outcomes after cadaver pancreas transplants. Am. J. Transplant 4, 605-610 (2004). (Pubitemid 38523583)
123. Nghiem, D. D., Olson, P R. & Ormond, D. The "fatty pancreas allograft": anatomopathologic findings and clinical experience. Transplant. Proc 36, 1045-1047 (2004). (Pubitemid 38766269)
124. Kaddis, J. S., Danobeitia, J. S., Niland, J. C., Stiller, T & Fernandez, L A. Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes. Am. J. Transplant 10, 646-656 (2010).
125. Hanley, S. C., Paraskevas, S. & Rosenberg, L. Donor and isolation variables predicting human islet isolation success. Transplantation 85, 950-955 (2008). (Pubitemid 351543156)
126. Cavallini, G., Frulloni, L., Vaona, B., Di, Francesco, V & Bovo, P Is hyperamylasemia related to dyslipidemia? Gastroenterology 112, 1058-1059 (1997).
127. Gullo, L. et al. Can. pancreatic steatosis explain the finding of pancreatic hyperenzymemia in subjects with dyslipidemia? Pancreas 33, 351-353 (2006). (Pubitemid 44690723)